Composition for treating vascular diseases characterized by nitric oxide insufficiency
US7537785B2 · kind B2 · utility
40Cited by
22References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 20, 2003 |
| Grant date | May 26, 2009 |
| Priority date | — |
| Expiry date | Jan 22, 2025 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/773
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a composition comprising an antioxidant, and at least one of isosorbide dinitrate and isosorbide mononitrate in therapeutically effective dosage of each of the aforementioned compounds to treat cardiovascular diseases caused by nitric oxide (NO) insufficiency. The antioxidant is a hydralazine compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.